scispace - formally typeset
T

Tucker W. LeBien

Researcher at University of Minnesota

Publications -  144
Citations -  12920

Tucker W. LeBien is an academic researcher from University of Minnesota. The author has contributed to research in topics: Bone marrow & B cell. The author has an hindex of 49, co-authored 144 publications receiving 11792 citations. Previous affiliations of Tucker W. LeBien include University of Nebraska Medical Center & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

The Molecular Taxonomy of Primary Prostate Cancer

Adam Abeshouse, +311 more
- 05 Nov 2015 - 
TL;DR: The Cancer Genome Atlas (TCGA) has been used for a comprehensive molecular analysis of primary prostate carcinomas as discussed by the authors, revealing substantial heterogeneity among primary prostate cancers, evident in the spectrum of molecular abnormalities and its variable clinical course.

The Molecular Taxonomy of Primary Prostate Cancer

Adam Abeshouse, +309 more
TL;DR: A comprehensive molecular analysis of 333 primary prostate carcinomas revealed a molecular taxonomy in which 74% of these tumors fell into one of seven subtypes defined by specific gene fusions (ERG, ETV1/4, and FLI1) or mutations (SPOP, FOXA1, and IDH1).
Journal ArticleDOI

B lymphocytes: how they develop and function

TL;DR: P perturbations in B-cell development that give rise to certain types of congenital immunodeficiency, leukemia/lymphoma, and autoimmune disease are discussed in the context of normal B- cell development and selection.
Journal ArticleDOI

Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins.

TL;DR: Correlations here suggest that cells entering B cell development express HLA-DR and rearrange heavy chain genes before the expression of a B cell-associated antigen recognized by the antibody BA-1, the antigen CALLA, and any subsequent light chain gene rearrangements.
Journal Article

A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage.

TL;DR: It is concluded that monoclonal antibody BA-1 may be useful in the study of early stages of human B lymphocyte development and shown weak reactivity with B lymphoblastoid cell lines and failed to react with multiple myeloma and pokeweed mitogen-induced plasma cells.